Anesthesia & Analgesia, Vol 82, 544-550, Copyright © 1996 by International Anesthesia Research Society

GENERAL ARTICLES

The effect of dexmedetomidine on the balance of myocardial energy requirement and oxygen supply and demand

CJ Lawrence, FW Prinzen and S de Lange
Department of Anesthesiology, University Hospital of Maastricht, The Netherlands.

The effect of the alpha(2)-adrenergic agonist dexmedetomidine on the balance between myocardial energy requirement and oxygen supply and demand was investigated in 16 open-chest dogs anesthetized with either chloralose/urethane (CU) or fentanyl/halothane (FH). Myocardial energy requirement (estimated from the pressure work index), blood flow and its transmural distribution (radioactive microspheres), as well as myocardial oxygen and lactate extraction, were measured before and after administration of dexmedetomidine in doses ranging from 0.1 to 10 micrograms/kg intravenously. Under CU anesthesia, dexmedetomidine decreased heart rate, arterial blood pressure, and cardiac output. During FH anesthesia, dexmedetomidine reduced heart rate and cardiac output whereas arterial blood pressure increased. Dexmedetomidine decreased myocardial energy requirement only during CU anesthesia; myocardial oxygen supply and demand decreased in parallel. At the (large) dose of 10 micrograms/kg, myocardial oxygen extraction increased during both types of anesthesia. Dexmedetomidine >/= 1 microgram/kg increased endocardial/epicardial blood flow ratio during FH anesthesia. These data indicate that dexmedetomidine >/= 1 microgram/kg reduces myocardial energy requirements, especially when baseline heart rate and blood pressure are increased. Dexmedetomidine preserves endocardial perfusion and reduces oxygen demand in parallel with oxygen supply and energy requirements.

This article has been cited by other articles:

				D. J. C. Alders, R. N. Cornelussen, F. W. Prinzen, P. A. C. Specht, M. I. M. Noble, A. J. Drake-Holland, F. J. J. de Kanter, and J. H. G. M. van Beek Heart/Cardiac Muscle: Regional sympathetic denervation affects the relation between canine local myocardial blood flow and oxygen consumption Exp Physiol, May 1, 2007; 92(3): 541 - 548. [Abstract] [Full Text] [PDF]

				H. M. Willigers, F. W. Prinzen, P. M. Roekaerts, S. de Lange, and M. E. Durieux Dexmedetomidine Decreases Perioperative Myocardial Lactate Release in Dogs Anesth. Analg., March 1, 2003; 96(3): 657 - 664. [Abstract] [Full Text] [PDF]

				E. Martin, G. Ramsay, J. Mantz, and S. T. J. Sum-Ping The Role of the {alpha}2-Adrenoceptor Agonist Dexmedetomidine in Postsurgical Sedation in the Intensive Care Unit J Intensive Care Med, January 1, 2003; 18(1): 29 - 41. [Abstract] [PDF]

				W. T. Schmeling and N. E. Farber The Effects of {alpha}2-Adrenergic Agonists on the Cardiovascular System Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 1997; 1(2): 178 - 196. [PDF]

Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999